RxDoctor Payments Data

Scott Schlauder

Dermatopathology · Kissimmee, FLNPI 1700030178

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Johnson & Johnson at 28.6% of the total. 2025 is the largest year on record at $423, more than ten times the $40 reported in 2019.

$962in general payments, 2019–2025

Across 32 payments — averaging $30.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$276
  • Strata Skin Sciences, Inc.$159
  • Organogenesis Inc.$115
  • Amgen$98
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$63
  • Sun Pharmaceutical Industries Inc.$45
  • plus $206 from 7 others

What the payments were for

  • Food & beverage$962100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$962 in reported general payments places this provider in the 75th percentile of 62 dermatopathology providers in Florida.

See all dermatopathology providers in Florida

Medicare billing

Part B allowed, 2024
$1,962,625
Medicare patients
1,957
Services billed
17,720

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Halobetasol Propionate27$1,642
Tacrolimus13$1,165
Doxycycline Hyclate42$930
Clobetasol Propionate19$869
Ketoconazole60$804
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip31$613
Imiquimod16$538
Fluocinolone Acetonide11$444
Triamcinolone Acetonide32$339
Mupirocin48$309
ValacyclovirValacyclovir Hcl13$233
Cephalexin17$108

Paid to pharmacies, not to this prescriber.

Other dermatopathology in Kissimmee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →